Isolagen Retains the Trout Group for Investor Relations
October 06 2005 - 8:30AM
PR Newswire (US)
EXTON, Pa., Oct. 6 /PRNewswire-FirstCall/ -- Isolagen, Inc.
(AMEX:ILE) announced today the engagement of the Trout Group to
provide institutional investor relations services to the Company.
The Trout Group provides investor relations and strategic advisory
services solely to the life sciences industry and has a global
reach with offices in New York, San Francisco and Boston. Over the
years, the Trout Group has developed a network of institutional
relationships with analysts, portfolio managers, investment bankers
and venture capitalists in the US biotechnology community. "Our
collaboration with the Trout Group is part of our corporate
strategy to expand the Company's shareholder base and to continue
to tell the story of Isolagen to the institutional investor
community," said Susan Ciallella, Chief Executive Officer of
Isolagen. ABOUT ISOLAGEN, INC. Isolagen specializes in the
development and commercialization of autologous cellular therapies
for soft and hard tissue regeneration. The company's product
candidates are based on its proprietary Isolagen Process. Based on
the accumulated experience of the company through its retrospective
study, clinical trials and treatment of patients in the United
Kingdom, the company believes that the Isolagen Process utilizes
the patient's own cells to create safe and effective therapies to
treat the underlying cause of the patient's condition. Autologous
cellular therapy is the process whereby a patient's own cells are
extracted, allowed to multiply and then injected into the patient.
Isolagen's product candidates are designed to be minimally invasive
and non-surgical. Forward-looking statements in this release are
made pursuant to the safe harbor provisions of the federal
securities laws. Information contained in forward-looking
statements is based on current expectations and is subject to
change, and actual results may differ materially from the
forward-looking statements. Isolagen, Inc. does not undertake to
update any such forward- looking statements or to publicly announce
developments or events relating to the matters described herein.
DATASOURCE: Isolagen, Inc. CONTACT: Lee M. Stern, x22, or Marcy
Strickler, x27, both of The Trout Group, +1-212-477-9007, for
Isolagen, Inc. Web site: http://www.isolagen.com/
Copyright
Isolagen (AMEX:ILE)
Historical Stock Chart
From Jun 2024 to Jul 2024
Isolagen (AMEX:ILE)
Historical Stock Chart
From Jul 2023 to Jul 2024